Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-28 Purchase |
2021-06-29 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting |
2,300 | $9 | $20,700 | 2,300 (Indirect) |
View |
| 2021-02-22 Sale |
2021-02-24 4:30 pm |
Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting |
5,000 | $14.72 | $73,582 | 65,683 (Direct) |
View |
| 2021-01-21 Sale |
2021-01-25 4:30 pm |
Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting |
6,607 | $14 | $92,498 | 15,212 (Direct) |
View |
| 2020-05-11 Sale |
2020-05-12 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting |
7,500 | $16 | $120,000 | 21,071 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-19 Option Award |
2022-01-21 4:15 pm |
N/A 2032-01-18 |
Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-24 4:30 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting |
5,000 | $7.84 | 65,683 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-24 4:30 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting |
5,000 | $0 | 65,683 (Direct) |
View |
| 2021-01-25 Option Award |
2021-01-27 4:30 pm |
N/A 2031-01-24 |
Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting |
40,000 | $0 | 40,000 (Direct) |
View |